Anúncio
Anúncio
SKYE
Skye Bioscience, Inc. Common Stock
0.98
USDPatrocinado
-0.07
-6.76%
09 de jan., 15:52 UTC -5
Encerrado
Pós-Mercado
1.00
+0.02
+1.84%
Relatórios de Lucros SKYE
Rácio de surpresa positiva
SKYE separação 5 de 9 últimas estimativas.
56%
Próximo Relatório
Data do Próximo Relatório
18 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.30
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-6.25%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+25.00%
Skye Bioscience, Inc. Common Stock earnings per share and revenue
On 10 de nov. de 2025, SKYE reported earnings of -0.32 USD per share (EPS) for Q3 25, beating the estimate of -0.33 USD, resulting in a 5.66% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of -0.30 USD, with revenue projected to reach -- USD, implying an diminuir of -6.25% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Skye Bioscience, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Skye Bioscience, Inc. Common Stock reported EPS of -$0.32, beating estimates by 5.66%, and revenue of $0.00, 0% as expectations.
How did the market react to Skye Bioscience, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 2.82%, changed from $1.42 before the earnings release to $1.46 the day after.
When is Skye Bioscience, Inc. Common Stock expected to report next?
The next earning report is scheduled for 18 de mar. de 2026.
What are the forecasts for Skye Bioscience, Inc. Common Stock's next earnings report?
Based on 10
analistas, Skye Bioscience, Inc. Common Stock is expected to report EPS of -$0.30 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio